RPG Life Sciences Limited Total Liabilities
RPG Life Sciences Limited total liabilities. Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has total liabilities worth Rs-6.05 Billion INR (≈ $-65.47 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RPG Life Sciences Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of RPG Life Sciences Limited (2005–2026)
Total liabilities of RPG Life Sciences Limited from 2005 to 2026. This chart illustrates how RPG Life Sciences Limited's total liabilities have evolved over time, based on quarterly financial data. Explore RPGLIFE long-term investments to assets to see how much of total assets are deployed in long-term investments.
RPG Life Sciences Limited Competitors by Total Liabilities
The table below lists competitors of RPG Life Sciences Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangxi Naipu Mining Machinery
SHE:300818
|
China | CN¥1.91 Billion |
|
Unizyx Holding Corp
TW:3704
|
Taiwan | NT$16.61 Billion |
|
Shenzhen Water Planning & Design Institute Co. Ltd.
SHE:301038
|
China | CN¥1.02 Billion |
|
China Haisum Engineering Co Ltd
SHE:002116
|
China | CN¥3.11 Billion |
|
Pansoft Company Limited
SHE:300996
|
China | CN¥169.81 Million |
|
Wanxiang Doneed Co Ltd
SHG:600371
|
China | CN¥126.60 Million |
|
Heliostar Metals Ltd
V:HSTR
|
Canada | CA$64.99 Million |
|
Tianjin Tianbao Infrastructure Co Ltd
SHE:000965
|
China | CN¥8.82 Billion |
Liability Composition Analysis (2005–2026)
This chart breaks down RPG Life Sciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see RPG Life Sciences Limited asset portfolio.
Liquidity & Leverage Metrics
RPG Life Sciences Limited Total Liabilities Ratios Explained
RPG Life Sciences Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RPG Life Sciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RPG Life Sciences Limited (2005–2026)
The table below shows the annual total liabilities of RPG Life Sciences Limited from 2005 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.88 Billion ≈ $20.31 Million |
+47.56% |
| 2025-03-31 | Rs1.27 Billion ≈ $13.76 Million |
-7.78% |
| 2024-03-31 | Rs1.38 Billion ≈ $14.93 Million |
+23.51% |
| 2023-03-31 | Rs1.12 Billion ≈ $12.09 Million |
+25.79% |
| 2022-03-31 | Rs888.40 Million ≈ $9.61 Million |
+2.19% |
| 2021-03-31 | Rs869.40 Million ≈ $9.40 Million |
-3.57% |
| 2020-03-31 | Rs901.60 Million ≈ $9.75 Million |
-0.64% |
| 2019-03-31 | Rs907.40 Million ≈ $9.81 Million |
-33.53% |
| 2018-03-31 | Rs1.37 Billion ≈ $14.76 Million |
+48.09% |
| 2017-03-31 | Rs921.90 Million ≈ $9.97 Million |
+28.69% |
| 2016-03-31 | Rs716.40 Million ≈ $7.75 Million |
-0.15% |
| 2015-03-31 | Rs717.50 Million ≈ $7.76 Million |
+2.05% |
| 2014-03-31 | Rs703.10 Million ≈ $7.60 Million |
-45.72% |
| 2013-03-31 | Rs1.30 Billion ≈ $14.01 Million |
+19.10% |
| 2012-03-31 | Rs1.09 Billion ≈ $11.76 Million |
-6.29% |
| 2011-03-31 | Rs1.16 Billion ≈ $12.55 Million |
+12.75% |
| 2010-03-31 | Rs1.03 Billion ≈ $11.13 Million |
-8.91% |
| 2009-03-31 | Rs1.13 Billion ≈ $12.22 Million |
-10.46% |
| 2008-03-31 | Rs1.26 Billion ≈ $13.65 Million |
-3.84% |
| 2007-03-31 | Rs1.31 Billion ≈ $14.19 Million |
-14.03% |
| 2006-03-31 | Rs1.53 Billion ≈ $16.51 Million |
-30.66% |
| 2005-03-31 | Rs2.20 Billion ≈ $23.81 Million |
-- |
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more